Continuous Glucose Monitoring (CGM) is a device that constantly measures blood glucose levels in real-time, providing people with diabetes a better understanding of how their bodies respond to different foods, activities, and medications. CGM devices consist of a small, disposable sensor that is inserted under the skin and connected to a transmitter that sends glucose readings to a receiver or smartphone app. The CGM system can also alert the user when glucose levels are too high or too low, helping them to take appropriate actions to manage their diabetes.
Advanced Therapy Replacement (ATR) is a new technology that combines CGM and insulin pump therapy into one device, allowing people with diabetes to manage their condition with fewer devices and fewer fingerstick tests. ATR technology automatically adjusts insulin delivery based on real-time glucose readings, helping to prevent hypoglycemia and hyperglycemia. ATR systems are still in development, but they have the potential to revolutionize diabetes management by providing a more seamless and personalized approach to diabetes care.